Banalan, Teodora O.

HRN: 25-01-53  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/12/2026
04/19/2026
IV
2.25
Q8
Cauti
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines